FFL
CRL icon

Financial Freedom LLC’s Charles River Laboratories CRL Stock Holding History

Financial Freedom LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43
Closed -$7.42K – 161
2026
Q1 		$7.42K Buy
+43
New +$7.97K ﹤0.01% 331

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Financial Freedom LLC's CRL Position: Q2 2026 in Review

Financial Freedom LLC sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 43 shares — an estimated $7.42K sold.

Financial Freedom LLC first reported a position in CRL in Q1 2026 and held it in 1 quarter. The position peaked at $7.42K in Q1 2026. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Financial Freedom LLC reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 43 Charles River Laboratories shares in Q2 2026, an estimated $7.42K.
  • Financial Freedom LLC first reported a position in Charles River Laboratories in Q1 2026 and held it in 1 quarter.
  • Financial Freedom LLC's Charles River Laboratories position peaked at $7.42K in Q1 2026.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.